Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities

Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme

(2020) Camille Taillé et al.   EUROPEAN RESPIRATORY JOURNAL

Anxiety and depression in adult patients with asthma: the role of asthma control, obesity and allergic sensitization

(2020) Martín Bedolla-Barajas et al.   JOURNAL OF ASTHMA

Impact of mepolizumab on exacerbations in severe asthma: Results from a U.S. insurance claims data base

(2020) Hector Ortega et al.   ALLERGY AND ASTHMA PROCEEDINGS

Mepolizumab improves patient outcomes and reduces exacerbations in severe asthma patients with comorbid upper airways disease

(2019) Charlene M. Prazma et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Evaluation and Management of Obesity Hypoventilation Syndrome. An Official American Thoracic Society Clinical Practice Guideline

(2019) Babak Mokhlesi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Economic burden of multimorbidity in patients with severe asthma: a 20-year population-based study

(2019) Wenjia Chen et al.   THORAX

Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR)

(2019) Wang Eileen et al.   CHEST

Effect of asthma control on general health-related quality of life in patients diagnosed with adult-onset asthma

(2019) Pinja Ilmarinen et al.   Scientific Reports

Barriers to medication adherence in asthma

(2018) Elizabeth L. McQuaid   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Factors reducing omalizumab response in severe asthma

(2018) B. Sposato et al.   European Journal of Internal Medicine

Obesity and asthma

(2018) Ubong Peters et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life

(2018) Dinh S Bui et al.   Lancet Respiratory Medicine

Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma

(2018) Hector Ortega et al.   Journal of Allergy and Clinical Immunology-In Practice

Asthma COPD overlap: Impact of associated comorbidities

(2018) Diego Jose Maselli et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma

(2017) Steven W. Yancey et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The High and Rising Costs of Obesity to the US Health Care System

(2017) Adam Biener et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA

(2017) Robert Y. Suruki et al.   BMC Pulmonary Medicine

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

(2017) Geoffrey L Chupp et al.   Lancet Respiratory Medicine

High probability of comorbidities in bronchial asthma in Germany

(2017) S. Heck et al.   npj Primary Care Respiratory Medicine

Relationships among Allergic Rhinitis, Asthma, and Chronic Rhinosinusitis

(2016) Mariel G. Rosati et al.   American Journal of Rhinology & Allergy

The economic costs of mental disorders

(2016) Sebastian Trautmann et al.   EMBO REPORTS

Excess medical costs in patients with asthma and the role of comorbidity

(2016) Wenjia Chen et al.   EUROPEAN RESPIRATORY JOURNAL

Corticosteroid pharmacokinetic abnormalities in overweight and obese corticosteroid resistant asthmatics

(2016) Elena Goleva et al.   Journal of Allergy and Clinical Immunology-In Practice

The Epidemiology of Anaphylaxis

(2015) Joyce E. Yu et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Trends and predictors of asthma costs: results from a 10-year longitudinal study

(2015) Ngiap Chuan Tan et al.   EUROPEAN RESPIRATORY JOURNAL

Acute and chronic systemic corticosteroid–related complications in patients with severe asthma

(2015) Patrick Lefebvre et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

(2014) Elisabeth H. Bel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

(2014) Hector G. Ortega et al.   NEW ENGLAND JOURNAL OF MEDICINE

Physical Deconditioning as a Cause of Breathlessness among Obese Adolescents with a Diagnosis of Asthma

(2014) Yun M. Shim et al.   PLoS One

Metabolic syndrome and incidence of asthma in adults: the HUNT study

(2013) Ben Michael Brumpton et al.   EUROPEAN RESPIRATORY JOURNAL

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

(2013) K. F. Chung et al.   EUROPEAN RESPIRATORY JOURNAL

Overweight/Obesity and Risk of Seasonal Asthma Exacerbations

(2013) Michael Schatz et al.   Journal of Allergy and Clinical Immunology-In Practice

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

(2012) Ian D Pavord et al.   LANCET

Ansiedade e depressão em pacientes com asma: impacto no controle da asma

(2011) Aline Arlindo Vieira et al.   Jornal Brasileiro de Pneumologia

Anxiety and depression in asthma

(2010) Fabiano Di Marco et al.   CURRENT OPINION IN PULMONARY MEDICINE

Obesity and Asthma Morbidity in a Community-Based Adult Cohort in a Large Urban Area: The Chicago Initiative to Raise Asthma Health Equity (CHIRAH)

(2010) Leslie C. Grammer et al.   JOURNAL OF ASTHMA

Role of infection in the development and exacerbation of asthma

(2010) Theresa W Guilbert et al.   Expert Review of Respiratory Medicine

Insulin resistance as a predictor of incident asthma-like symptoms in adults

(2009) B. H. Thuesen et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

(2008) J. Bousquet et al.   ALLERGY